{"id":955368,"title":"Chapter 4: Cancer incidence in Canada: trends and projections (1983-2032) – Leukemia - HPCDP: Volume 35, Supplement 1, Spring 2015 - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-04-26","captureTimestamp":"2026-04-26T19:34:36.027000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-35-no-1-2015/supplement/page-17.html","snippet":"Chapter 4: Cancer incidence in Canada: trends and projections (1983-2032) – Leukemia - HPCDP: Volume 35, Supplement 1, Spring 2015 Previous page Table of Contents Next page Chapter 4: Projections by Cancer Site 23. Leukemia Leukemia is the second most common lymphohematopoietic…","rawSnapshotUrl":"/api/snapshots/raw/955368","browseUrl":"https://replay.healtharchive.ca/job-7/20260426193436/https://www.canada.ca/en/public-health/services/reports-publications/health-promotion-chronic-disease-prevention-canada-research-policy-practice/vol-35-no-1-2015/supplement/page-17.html#ha_snapshot=955368","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}